- Home
- IPST vs MTNB Comparison
IPST vs MTNB Comparison
Compare IPST & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPST | MTNB |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.6M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IPST | MTNB |
|---|---|---|
| Price | $2.56 | $1.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 249.9K | 142.9K |
| Earning Date | 11-17-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,402,488.00 | $119,750.00 |
| Revenue This Year | $66.82 | N/A |
| Revenue Next Year | $60.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $0.26 | $0.15 |
| 52 Week High | $308.00 | $3.16 |
Technical Indicators
Market Signals| Indicator | IPST | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 40.26 | 49.18 |
| Support Level | $2.18 | $0.56 |
| Resistance Level | $2.80 | $3.16 |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.02 | -0.19 |
| Stochastic Oscillator | 26.85 | 16.31 |
Price Performance
Historical ComparisonAbout IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.